latest news releases from the newsroom
Pyrosequencing AB: Decision on new share issue
UPPSALA, Sweden, Oct. 23, 2003 (PRIMEZONE) -- Pyrosequencing AB ("Pyrosequencing") (Stockholm:PYROA) announces that the Board of Pyrosequencing today decided on, based on the authorization from the extraordinary general meeting on September 25, 2003, a non-cash issue of a maximum of 56,613 ordinary shares and an issue of debentures together with a maximum of 52,238 warrants for subscription of a maximum of 52,238 new ordinary shares in the Company. The issues are made due to acquisitions of additional shares in Personal Chemistry in Uppsala AB ("Personal Chemistry"). Each new warrant issued will have a term of 4 years and entitle the holder to subscribe for a new ordinary share in Pyrosequencing at an exercise price of SEK 16 (approximately $ 2 USD). The right to subscribe for the shares and the debentures together with warrants is limited to those shareholders in Personal Chemistry who have signed an agreement with Pyrosequencing regarding the transfer of their shares in Personal Chemistry in exchange for new ordinary shares and debentures together with warrants in Pyrosequencing. The same conditions apply to these issues as in connection with previous acquisitions of shares in Personal Chemistry.
Harsco's Third Quarter 2003 Diluted Earnings Per Share Total $0.69
HARRISBURG, Pa., Oct. 23, 2003 (PRIMEZONE) -- Worldwide industrial services and products company Harsco Corporation (NYSE:HSC) today reported diluted earnings per share totaling $0.69 in the third quarter of 2003, compared with $0.63 in the third quarter of 2002. Net income was $28.5 million, compared with $25.7 million last year. Income from continuing operations was $23.4 million, or $0.57 diluted earnings per share, compared with income from continuing operations of $24.7 million, or $0.61 diluted earnings per share in the third quarter of 2002. Income from discontinued operations for the third quarter 2003 was $5.1 million, or $0.12 diluted earnings per share, reflecting favorable developments in the Company's Federal Excise Tax litigation, as discussed under the Discontinued Operations section below. Third quarter 2003 sales totaled $530 million, up approximately four percent from sales of $511 million in the same period last year.
The World Golf League, Inc.
The WGL Projects Record First Quarter 2004 Revenue
ALTAMONTE SPRINGS, Fla., Oct. 23, 2003 (PRIMEZONE) -- The WGL, Inc. (OTCBB:WGFL) announced today that it expects gross revenue for the first quarter ending March 31, 2004 to exceed $7.80 million with pre-tax income estimated at $2.20 million. The estimates are based on 65,000 new members in the first quarter of 2004 contributing $6.8 million and the WGL telemarketing program contributing $1.05 million.
Annual General Meeting of Provalis PLC
DEESIDE, Flintshire, U.K., Oct. 23, 2003 (PRIMEZONE) -- Provalis PLC: At todays Annual General Meeting of Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, Frank Harding, Chairman, made the following statement.
Brock comments on Atlas Copco's Q3 results, 2003
STOCKHOLM, Sweden, Oct. 23, 2003 (PRIMEZONE) -- Today, the Atlas Copco Group reported its third quarter results. "The order volume turned positive and we have achieved an improved profitability," said Gunnar Brock, President and CEO. "The increase in volume, continued efficiency measures, and price increases all added to the positive results."